Literature DB >> 29322405

Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer.

Sarah A Best1,2, Ariena Kersbergen1, Marie-Liesse Asselin-Labat1,2, Kate D Sutherland3,4.   

Abstract

Lung cancers display considerable intertumoral heterogeneity, leading to the classification of distinct tumor subtypes. Our understanding of the genetic aberrations that underlie tumor subtypes has been greatly enhanced by recent genomic sequencing studies and state-of-the-art gene targeting technologies, highlighting evidence that distinct lung cancer subtypes may be derived from different "cells-of-origin". Here, we describe the intra-tracheal delivery of cell type-restricted Ad5-Cre viruses into the lungs of adult mice, combined with immunohistochemical and flow cytometry strategies for the detection of lung cancer-initiating cells in vivo.

Entities:  

Keywords:  Cells-of-origin; Flow cytometry; Immunohistochemical staining; Intra-tracheal injection; Recombinant adenovirus; Tissue dissociation

Mesh:

Substances:

Year:  2018        PMID: 29322405     DOI: 10.1007/978-1-4939-7568-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Studying the immune landscape in lung cancer models: choosing the right experimental tools.

Authors:  Clare E Weeden; Casey Ah-Cann; Marie-Liesse Asselin-Labat
Journal:  Transl Lung Cancer Res       Date:  2018-09

Review 2.  "Keaping" a lid on lung cancer: the Keap1-Nrf2 pathway.

Authors:  Sarah A Best; Kate D Sutherland
Journal:  Cell Cycle       Date:  2018-08-01       Impact factor: 4.534

3.  Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma.

Authors:  Sarah A Best; Sheryl Ding; Ariena Kersbergen; Xueyi Dong; Ji-Ying Song; Yi Xie; Boris Reljic; Kaiming Li; James E Vince; Vivek Rathi; Gavin M Wright; Matthew E Ritchie; Kate D Sutherland
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

4.  Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis.

Authors:  Lahiru Gangoda; Robyn L Schenk; Sarah A Best; Christina Nedeva; Cynthia Louis; Damian B D'Silva; Kirsten Fairfax; Andrew G Jarnicki; Hamsa Puthalakath; Kate D Sutherland; Andreas Strasser; Marco J Herold
Journal:  Cell Death Differ       Date:  2021-07-24       Impact factor: 15.828

5.  FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium.

Authors:  Sarah A Best; Cassandra R Harapas; Ariena Kersbergen; Vivek Rathi; Marie-Liesse Asselin-Labat; Kate D Sutherland
Journal:  Oncogene       Date:  2018-07-10       Impact factor: 9.867

6.  Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.

Authors:  Sarah A Best; Cassandra J Vandenberg; Etna Abad; Lachlan Whitehead; Laia Guiu; Sheryl Ding; Margs S Brennan; Andreas Strasser; Marco J Herold; Kate D Sutherland; Ana Janic
Journal:  Cell Death Dis       Date:  2020-10-20       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.